Geoffrey Lynn, SVP, Synthetic Immunotherapies, Vaccitech, joins BioTalk to discuss his career from NIH, to CEO of Avidea, to their merger with Vaccitech.
Information
- Show
- FrequencyUpdated Biweekly
- PublishedFebruary 7, 2022 at 5:00 AM UTC
- Length34 min
- Episode101
- RatingClean